The roots of grass-roots "into new medical reform under the direction of multinational medical apparatus group new

Not long ago, foreign medical giants in the medical device market in China is only concerned about the "high end", and the Chinese medical device up to 70% of the top products from the import of multinational pharmaceutical group, CIC consultants pharmaceutical industry researcher Guo, and where the ceremony that the new reform of steadily, the roots of grass-roots "into these multinational medical device group new direction of development.

Investment advisor in the pharmaceutical industry researcher Guo Li stated that where the so-called "deep grass-roots" refers to the past on my primary medical market shrugs off of multinational pharmaceutical group began slowly to enter this area, they begin to develop applicable to our local medical products, the production base in China and the research and Development Center and launch more focused strategies into our primary medical market.

Guo where the ceremony that, while they are doing all of this is that smell "new health reform" this big cake tastes, the medical and health system reform in the recent focus on the implementation of the programme made clear, the next three years will focus on supporting 2000 the County Hospital construction and 2.9 million construction of the commune, and at the same time extending the Township Central 5000.

On the other hand, the new health reform 8500 billion invested in 165 billion in all targeted at the national 2.9 million rural hospitals and urban community health service, all as part of their medical equipment purchase subsidy, this year our country will invest $ 37 billion for the national 70 per cent of the County Hospital of reconstruction and expansion, including updates and upgrades of grass-roots organizations medical device products.

Guo where rituals noted that these policies in the interpretation of the multinational medical device Giants have come under a benefit as a result, including Siemens, GE, Philips, global medical device magnates accelerated entry into China's primary health care sector, their strategy from the previous high-end policy shifts to primary health care market, there is no doubt that the new reform to promote primary health care market volume is a tempting cake, but the roots of grass-roots "has also become a new multinational medical device under the medical reform group's new direction.